Evidence map›Paper›PMID 38282935›Full record

ArticleMediterranean journal of rheumatology2023

Quality-of-Life Endpoints in Women of Childbearing Age with Hidradenitis Suppurativa: A Tertiary-Care-Centre-Based Study.

Aikaterini Tsentemeidou, Elena Sotiriou, Katerina Bakirtzi, Ilias Papadimitriou, Themis Chatzi-Sotiriou, Angeliki Panagopoulou, Nikolaos Kougkas, Aimilios Lallas, Efstratios Vakirlis

Open access · diamondAbstract read
In one paragraph

Article in Mediterranean journal of rheumatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Aikaterini TsentemeidouFirst Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Elena SotiriouFirst Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Katerina BakirtziFirst Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Ilias PapadimitriouFirst Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Themis Chatzi-SotiriouDepartment of International and European Studies, School of Social Sciences, Humanities and Arts, University of Macedonia, Thessaloniki, Greece.
Angeliki PanagopoulouFirst Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Nikolaos KougkasFourth Department of Internal Medicine, Aristotle University of Thessaloniki, Greece.
Aimilios LallasFirst Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Efstratios VakirlisFirst Department of Dermatology and Venereology, School of Medicine, Aristotle University, Thessaloniki, Greece.
Aristotle University of Thessaloniki · GRUniversity of Macedonia · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hidradenitis suppurativa (HS) principally affects women of childbearing age, who face gender-specific challenges and have lower life-quality than men. HS also seems to impact desire for procreation. Objective: To investigate various quality-of-life endpoints in women of childbearing age with HS. Study design: A cross-sectional questionnaire-based study was performed at a university dermatology department. Eighteen yes/no and one open-ended questions explored impact of HS on social life, sexual life, family planning, working life and healthcare-backed support. A sensitivity analysis was performed for women under 25, who are significantly less likely to be married/in a permanent relationship in Greece, as this could act as a confounding factor regarding family planning. Results: Ninety-six women were included. Most women (80.8%) carry a stigma because of HS, which also affects their choice of clothes and social relationships. Sexual impairment affects 73.1% of women. One third of women wants less or no children because of HS, 67.7% worry about its impact on pregnancy, birth, and the postpartum, and 84.6% worry about the impact of HS treatment on fertility and their babies' health. Almost 43% fear losing their job because of HS, 34.4% are discriminated against at work and 33.3% state HS has hindered their career. Most women are not adequately informed about their disease or available support groups/material and 41.7% have not received good enough care through pregnancy/postpartum. Conclusions: Life-quality endpoints should be meticulously screened in women. Multidisciplinary-led treatment should be offered during pregnancy and the postpartum.

Indexed as

childbearing agefemalehidradenitis suppurativapregnancyquality of lifewomen

Identifiers

PMID38282935
PMCPMC10815518
OpenAlexW4391909269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.